jk

I've tried to respond to your pm twice but receive the following error

You don't have permission to access /members/chicagoest/private-messages on this server.

I have emailed agoracom tech for a fix

I scanned the financials but haven't had time to study them. No change in the royalty agreement liability computation other than a change in the market interest rate - but no reference to trial results or increased probability - noted a cash hit and can't quite pin it down (due to RVX cash shift to Zenith and clinical trial start-up costs?) - cash outflow has been substantially greater than 2mm per month(which most likely covers operations and the trial only) - I wanted to take a better look at the cash flow statement - cash decreased from $42,412 at 10/31/15 to $29,927 at 1/31/16 (in thousands USD) - that's a hit of $12mm for the last quarter - substantially greater than 2MM per mo - at last quarters burn rate of 4.162 mm per mo -rvx out of cash in 7 mos. the recent cash flow statement is for the past nine months - need to see a quarterly cash flow statement - my hope is that management continues to focus on the clinical trial and successfully achieving endpoints - there is not much room for error

I will be out of action for at least a month due to my heavy workload

Still patient

Chicagoest